Treatment of Painful Diabetic Polyneuropathy with Mixed Gangliosides
- 1 January 1984
- book chapter
- Published by Springer Nature
- Vol. 174, 581-592
- https://doi.org/10.1007/978-1-4684-1200-0_49
Abstract
Peripheral neuropathy is a common complication of diabetes mellitus1 with an incidence of from 15% to 60%.2,3,4 While estimates vary, as many as 20% of these patients may suffer from considerable painful discomfort.5 Control of blood glucose has been demonstrated to improve motor nerve conduction in diabetic rats and humans,7,8 though this may not improve peripheral nerve function. Treatment of painful diabetic neuropathy has had variable success, and as an attempt to deal with this serious problem, this study was initiated.This publication has 18 references indexed in Scilit:
- Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normalsActa Neurologica Scandinavica, 1983
- Has One Diabetic Complication Been Explained?New England Journal of Medicine, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983
- The Causes, Classification, and Treatment of Peripheral NeuropathyNew England Journal of Medicine, 1982
- Ganglioside Stimulation of Axonal Sprouting in VitroScience, 1981
- Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometryAnnals of Neurology, 1980
- Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growthBrain Research, 1980
- Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies?Annals of Neurology, 1979
- A comparison of membrane glycoconjugates from mouse cells transformed by murine and primate RNA sarcoma virusesBiochemistry, 1976
- Juvenile diabetes mellitus after forty yearsDiabetes, 1975